This invention relates to the compounds or a pharmaceutical acceptable salts, hydrates or solvates thereof, which are inhibitors of cysteine proteases, in particular of cathepsin B. Compounds of the invention are useful in the treatment of diseases in which cathepsin B is implicated.
F.06 Development of a new product
COBISS.SI-ID: 3156849Ph. D. thesis describes various modes of regulation of carboxypeptidase and endopeptidase activity of cysteine protease cathepsin B.
D.09 Tutoring for postgraduate students
COBISS.SI-ID: 2978673